ByteDance completes $290M fundraising for AI drug unit
ByteDance has completed a $290 million fundraising for its AI drugmaking unit after spinning it off, sources said. The unit is Shanghai-headquartered Anew Labs, which uses AI for drug discovery.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.